Bodera Filip J, McVey Mark J, Sathiyamoorthy Krishnan, Kolios Michael C
Department of Physics, Toronto Metropolitan University, Toronto, Canada.
Institute for Biomedical Engineering, Science and Technology, Li Ka Shing Knowledge Institute, Keenan Research Centre, St. Michael's Hospital, Toronto, Canada.
Photoacoustics. 2023 Apr 7;30:100487. doi: 10.1016/j.pacs.2023.100487. eCollection 2023 Apr.
Clotting is a physiological process that prevents blood loss after injury. An imbalance in clotting factors can lead to lethal consequences such as exsanguination or inappropriate thrombosis. Clinical methods to monitor clotting and fibrinolysis typically measure the viscoelasticity of whole blood or optical density of plasma over time. Though these methods provide insights into clotting and fibrinolysis, they require milliliters of blood which can worsen anemia or only provide partial information. To overcome these limitations, a high-frequency photoacoustic (HFPA) imaging system was developed to detect clotting and lysis in blood. Clotting was initiated in vitro in reconstituted blood using thrombin and lysed with urokinase plasminogen activator. Frequency spectra measured using HFPA signals (10-40 MHz) between non-clotted blood and clotted blood differed markedly, allowing tracking of clot initiation and lysis in volumes of blood as low as 25 µL/test. HFPA imaging shows potential as a point-of-care examination of coagulation and fibrinolysis.
凝血是一种生理过程,可防止受伤后失血。凝血因子失衡会导致致命后果,如失血过多或不当血栓形成。监测凝血和纤维蛋白溶解的临床方法通常是测量全血的粘弹性或血浆随时间的光密度。尽管这些方法能洞察凝血和纤维蛋白溶解情况,但它们需要数毫升血液,这可能会加重贫血或只能提供部分信息。为克服这些局限性,开发了一种高频光声(HFPA)成像系统来检测血液中的凝血和溶解。使用凝血酶在体外重构血液中引发凝血,并用尿激酶纤溶酶原激活剂使其溶解。使用HFPA信号(10 - 40 MHz)测量的非凝血血液和凝血血液之间的频谱有显著差异,从而能够在低至25 μL/测试的血液量中追踪凝血起始和溶解情况。HFPA成像显示出作为凝血和纤维蛋白溶解即时检验的潜力。